Table 5 Camp Lejeune vs Camp Pendleton: hazard ratios and 95% confidence intervals, adjusted by sex, race, rank and education, 10-year lag

All cancers

1.10

1.00

1.20

0.02

Diseases of primary interest

Kidney cancer

1.35

0.84

2.16

0.19

Bladder cancer

0.76

0.34

1.71

0.50

Liver* cancer

1.42

0.92

2.20

0.11

Esophageal cancer

1.43

0.85

2.38

0.17

Hematopoietic cancers

1.05

0.82

1.33

0.57

Hodgkin

1.47

0.71

3.06

0.26

NHL**

0.81

0.56

1.18

0.43

Multiple myeloma

1.68

0.76

3.72

0.21

Leukemias

1.11

0.75

1.62

0.63

Cervical cancer

1.33

0.24

7.32

0.74

Diseases of secondary interest

Pancreatic cancer

1.36

0.91

2.02

0.13

Colorectal cancers

1.13

0.85

1.51

0.35

Colon cancer

1.04

0.75

1.43

0.76

Rectal cancer

1.60

0.83

3.07

0.15

Soft tissue cancers

1.38

0.73

2.64

0.30

Brain cancer

0.93

0.67

1.30

0.84

Laryngeal cancer

0.54

0.20

1.45

0.22

Lung*** cancer

1.16

0.96

1.40

0.10

Oral cancers****

0.82

0.48

1.41

0.46

Breast (female) cancer

0.93

0.34

2.50

0.88

Prostate cancer

1.23

0.60

2.49

0.57

Liver diseases

0.87

0.71

1.06

0.18

Kidney diseases

1.00

0.63

1.63

0.95

ALS

0.83

0.47

1.48

0.54

Multiple sclerosis

1.21

0.50

2.94

0.65

Smoking-related diseases (not known to be related to solvent exposure)

Stomach cancer

1.15

0.70

1.90

0.58

Cardiovascular disease†

1.04

0.95

1.11

0.31

COPD

1.08

0.70

1.67

0.70